John Bencich
2020
In 2020, John Bencich earned a total compensation of $883.7K as Chief Executive Officer and Former Chief Financial Officer and Chief Operating Officer at OncoGenex Pharmaceuticals, a 55% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $199,610 |
---|---|
Option Awards | $263,208 |
Salary | $420,914 |
Total | $883,732 |
Bencich received $420.9K in salary, accounting for 48% of the total pay in 2020.
Bencich also received $199.6K in non-equity incentive plan and $263.2K in option awards.
Rankings
In 2020, John Bencich's compensation ranked 9,118th out of 13,090 executives tracked by ExecPay. In other words, Bencich earned more than 30.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,118 | 30th |
Manufacturing | 3,898 | 31st |
Chemicals And Allied Products | 1,579 | 30th |
Drugs | 1,380 | 29th |
In Vitro and In Vivo Diagnostic Substances | 39 | 35th |
Bencich's colleagues
We found two more compensation records of executives who worked with John Bencich at OncoGenex Pharmaceuticals in 2020.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019